Shionogi-ViiV Healthcare LLC Announces Initial Data from Pivotal Phase III Study of Dolutegravir in HIV
4/2/2012 11:19:56 AM
More...
|
Shionogi-ViiV Healthcare LLC Starts Phase III Trial for '572-Trii' Fixed-Dose Combination HIV Therapy
2/3/2011 8:25:36 AM
More...
|
Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Program for Investigational Once-Daily HIV Integrase Inhibitor
10/21/2010 7:35:08 AM
More...
|
Shionogi-ViiV Healthcare LLC Presents Positive Data on Investigational Once-Daily Integrase Inhibitor at International AIDS Conference
7/22/2010 11:53:05 AM
More...
|
GlaxoSmithKline (GSK), Shionogi-ViiV Healthcare LLC Take New AIDS Drug into Final-Stage Tests
7/21/2010 6:40:58 AM
More...
|